Duvyzat (Givinostat) in Duchenne Muscular Dystrophy: Mechanisms, Clinical Impact, and Future Directions. Current Pharmaceutical Research, [S. l.], v. 1, n. 3, p. 308–322, 2025. DOI: 10.63785/cpr.2025.1.3.308322. Disponível em: https://cpr.org.in/index.php/files/article/view/145. Acesso em: 15 jan. 2026.